Interactions Between Glycogen Synthase Kinase-3β Gene Polymorphisms, Negative Life Events, and Susceptibility to Major Depressive Disorder in a Chinese Population

Overview

Journal Front Psychiatry

Specialty Psychiatry

Date 2021 Mar 4

PMID 33658947

Citations 6

Authors

Jiarun Yang

Siyuan Ke

Zhengxue Qiao

Xiuxian Yang

Xiaohui Qiu

Xuejia Song

Erying Zhao

Jiawei Zhou

Mingzhe Zhao

Yanjie Yang

Deyu Fang

Depin Cao

Affiliations

Soon will be listed here.

Abstract

Recent studies suggest that glycogen synthase kinase (GSK)-3β is involved in the development of major depressive disorder (MDD). The aim of this study was to investigate the interaction between GSK-3β polymorphism (rs6438552, rs334558, and rs2199503) and negative life events in the pathogenesis of major depressive disorder (MDD). DNA genotyping was performed on peripheral blood leukocytes in 550 patients with MDD and 552 age- and gender-matched controls. The frequency and severity of negative life events were assessed by the Life Events Scale (LES). A chi-square method was employed to assess the gene-environment interaction (G × E). Differences in rs6438552, rs334558, and rs2199503 genotype distributions were observed between MDD patients and controls. Significant G × E interactions between allelic variation of rs6438552, rs334558, and rs2199503 and negative life events were observed. Individuals with negative life events and carrying genotypes of rs6438552 A, rs334558 A, and rs2199503G have increased the risk of depression. These results indicate that interactions between the GSK-3β rs6438552, rs334558, and rs2199503 polymorphisms and environment increases the risk of developing MDD.

Citing Articles

The links between neuroinflammation, brain structure and depressive disorder: A cross-sectional study protocol.

Milasauskiene E, Burkauskas J, Jesmanas S, Gleizniene R, Borutaite V, Skemiene K PLoS One. 2024; 19(11):e0311218.

PMID: 39565757 PMC: 11578540. DOI: 10.1371/journal.pone.0311218.

The association among negative life events, alexithymia, and depressive symptoms in a psychosomatic outpatient sample.

Xie Y, Ma D, Duan Y, Cao J, Wei J BMC Psychiatry. 2024; 24(1):451.

PMID: 38890601 PMC: 11186062. DOI: 10.1186/s12888-024-05902-0.

Epigenetic Orchestration of Neurodegenerative Disorders: A Possible Target for Curcumin as a Therapeutic.

Tripathi S, Bhawana Neurochem Res. 2024; 49(9):2319-2335.

PMID: 38856890 DOI: 10.1007/s11064-024-04167-z.

Immature defense mechanisms mediate the relationship between negative life events and depressive symptoms.

Ma D, Cao J, Wei J, Jiang J Front Psychiatry. 2024; 14:1341288.

PMID: 38274424 PMC: 10808586. DOI: 10.3389/fpsyt.2023.1341288.

GSK3β rs3107669 polymorphism implicates chemotherapy-associated retrospective memory deficits in breast cancer survivors.

Li W, Gan C, Yu S, Xu J, Tang L, Li Q Am J Cancer Res. 2023; 13(10):4961-4975.

PMID: 37970370 PMC: 10636677.

References

Ripke S, Wray N, Lewis C, Hamilton S, Weissman M, Breen G . A mega-analysis of genome-wide association studies for major depressive disorder. Mol Psychiatry. 2012; 18(4):497-511. PMC: 3837431. DOI: 10.1038/mp.2012.21. View

Inkster B, Nichols T, Saemann P, Auer D, Holsboer F, Muglia P . Association of GSK3beta polymorphisms with brain structural changes in major depressive disorder. Arch Gen Psychiatry. 2009; 66(7):721-8. DOI: 10.1001/archgenpsychiatry.2009.70. View

Karege F, Perroud N, Burkhardt S, Schwald M, Ballmann E, La Harpe R . Alteration in kinase activity but not in protein levels of protein kinase B and glycogen synthase kinase-3beta in ventral prefrontal cortex of depressed suicide victims. Biol Psychiatry. 2006; 61(2):240-5. DOI: 10.1016/j.biopsych.2006.04.036. View

Rybakowski J, Abramowicz M, Szczepankiewicz A, Michalak M, Hauser J, Czekalski S . The association of glycogen synthase kinase-3beta (GSK-3β) gene polymorphism with kidney function in long-term lithium-treated bipolar patients. Int J Bipolar Disord. 2014; 1:8. PMC: 4230305. DOI: 10.1186/2194-7511-1-8. View

Hooper C, Killick R, Lovestone S . The GSK3 hypothesis of Alzheimer's disease. J Neurochem. 2007; 104(6):1433-9. PMC: 3073119. DOI: 10.1111/j.1471-4159.2007.05194.x. View

Gaspersz R, Lamers F, Wittenberg G, Beekman A, van Hemert A, Schoevers R . The role of anxious distress in immune dysregulation in patients with major depressive disorder. Transl Psychiatry. 2017; 7(12):1268. PMC: 5802575. DOI: 10.1038/s41398-017-0016-3. View

Levchenko A, Losenkov I, Vyalova N, Simutkin G, Bokhan N, Wilffert B . The functional variant rs334558 of is associated with remission in patients with depressive disorders. Pharmgenomics Pers Med. 2018; 11:121-126. PMC: 6055890. DOI: 10.2147/PGPM.S171423. View

Inkster B, Nichols T, Saemann P, Auer D, Holsboer F, Muglia P . Pathway-based approaches to imaging genetics association studies: Wnt signaling, GSK3beta substrates and major depression. Neuroimage. 2010; 53(3):908-17. DOI: 10.1016/j.neuroimage.2010.02.065. View

Yang C, Xu Y, Sun N, Ren Y, Liu Z, Cao X . The combined effects of the BDNF and GSK3B genes modulate the relationship between negative life events and major depressive disorder. Brain Res. 2010; 1355:1-6. DOI: 10.1016/j.brainres.2010.07.079. View

10.

OLeary O, Nolan Y . Glycogen synthase kinase-3 as a therapeutic target for cognitive dysfunction in neuropsychiatric disorders. CNS Drugs. 2014; 29(1):1-15. DOI: 10.1007/s40263-014-0213-z. View

11.

Wang C, Wu H, Chen F, Xu J, Li H, Li H . Disrupted functional connectivity patterns of the insula subregions in drug-free major depressive disorder. J Affect Disord. 2018; 234:297-304. DOI: 10.1016/j.jad.2017.12.033. View

12.

Zhao M, Yang J, Qiu X, Yang X, Qiao Z, Song X . , Threatening Life Events, and Gene-Environment Interaction Predict Major Depressive Disorder. Front Psychiatry. 2020; 10:982. PMC: 6987424. DOI: 10.3389/fpsyt.2019.00982. View

13.

Liu S, Sun N, Xu Y, Yang C, Ren Y, Liu Z . Possible association of the GSK3β gene with the anxiety symptoms of major depressive disorder and P300 waveform. Genet Test Mol Biomarkers. 2012; 16(12):1382-9. PMC: 3501115. DOI: 10.1089/gtmb.2012.0227. View

14.

Fukuda T, Kokabu S, Ohte S, Sasanuma H, Kanomata K, Yoneyama K . Canonical Wnts and BMPs cooperatively induce osteoblastic differentiation through a GSK3beta-dependent and beta-catenin-independent mechanism. Differentiation. 2010; 80(1):46-52. DOI: 10.1016/j.diff.2010.05.002. View

15.

Costemale-Lacoste J, Colle R, Martin S, El Asmar K, Loeb E, Feve B . Glycogen synthase kinase-3β genetic polymorphisms and insomnia in depressed patients: A prospective study. J Affect Disord. 2018; 240:230-236. DOI: 10.1016/j.jad.2018.07.062. View

16.

Binder E, Nemeroff C . The CRF system, stress, depression and anxiety-insights from human genetic studies. Mol Psychiatry. 2009; 15(6):574-88. PMC: 3666571. DOI: 10.1038/mp.2009.141. View

17.

Kendler K, Baker J . Genetic influences on measures of the environment: a systematic review. Psychol Med. 2006; 37(5):615-26. DOI: 10.1017/S0033291706009524. View

18.

Roh M, Eom T, Zmijewska A, De Sarno P, Roth K, Jope R . Hypoxia activates glycogen synthase kinase-3 in mouse brain in vivo: protection by mood stabilizers and imipramine. Biol Psychiatry. 2005; 57(3):278-86. DOI: 10.1016/j.biopsych.2004.10.039. View

19.

Thompson S, Kallarackal A, Kvarta M, Van Dyke A, LeGates T, Cai X . An excitatory synapse hypothesis of depression. Trends Neurosci. 2015; 38(5):279-94. PMC: 4417609. DOI: 10.1016/j.tins.2015.03.003. View

20.

Benedetti F, Poletti S, Radaelli D, Locatelli C, Pirovano A, Lorenzi C . Lithium and GSK-3β promoter gene variants influence cortical gray matter volumes in bipolar disorder. Psychopharmacology (Berl). 2014; 232(7):1325-36. DOI: 10.1007/s00213-014-3770-4. View